MetaADEDB 2.0 @ LMMD
iopromide
(DGAIEPBNLOQYER-UHFFFAOYSA-N)
Structure
SMILES
COCC(=O)Nc1c(I)c(C(=O)NCC(CO)O)c(c(c1I)C(=O)N(CC(CO)O)C)I
Type(s)
Approved
ATC code(s)
V08AB05
Molecular Formula:
C18H24I3N3O8
Molecular Weight:
791.112
Log P:
0.0574
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
6
TPSA:
168.66
CAS Number(s):
73334-07-3
Synonym(s)
1.
iopromide
2.
Clarograf
3.
N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide
4.
Ultravist
5.
Ultravist 300
6.
iopromid
7.
lopromid
External Link(s)
MeSHC038192
PubChem Compound3736
ChEBI63578
CHEMBLCHEMBL1725
DrugBankDB09156
DrugCentral1468
KEGGdr:D01893
Therapeutic Target DatabaseD07GNP
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1UrticariaFAERS: 1447
Canada Vigilance: 4
9211770
16628721
CTD
SIDER
Canada Vigilance
US FAERS
2PruritusFAERS: 624
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
3ErythemaFAERS: 371
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
4NauseaFAERS: 355
Canada Vigilance: 3
9211770CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
5VomitingFAERS: 346
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6SneezingFAERS: 332
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7Contrast media reactionFAERS: 206
Canada Vigilance: 1
Canada Vigilance
US FAERS
8Anaphylactic shockFAERS: 197SIDER
US FAERS
9Chest discomfortFAERS: 146SIDER
US FAERS
10Throat irritationFAERS: 145SIDER
US FAERS
11Cardiac ArrestFAERS: 139SIDER
US FAERS
12HypotensionFAERS: 137
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
13FlushingFAERS: 124SIDER
US FAERS
14Adverse eventFAERS: 111OFFSIDES
US FAERS
15DizzinessFAERS: 107SIDER
US FAERS
16HypersensitivityFAERS: 105SIDER
US FAERS
17ChillsFAERS: 93SIDER
US FAERS
18Respiratory arrestFAERS: 87SIDER
US FAERS
19CyanosisFAERS: 86OFFSIDES
SIDER
US FAERS
20HeadacheFAERS: 75SIDER
US FAERS
21Lip swellingFAERS: 73
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
22TremorFAERS: 71SIDER
US FAERS
23Chest PainFAERS: 68
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24ShockFAERS: 60SIDER
US FAERS
25PallorFAERS: 55SIDER
US FAERS
26TachycardiaFAERS: 55SIDER
US FAERS
27DysphoniaFAERS: 51
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
28ExtravasationFAERS: 49
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
29Urinary IncontinenceFAERS: 49US FAERS
30Depressed Level of ConsciousnessFAERS: 48US FAERS
31WheezingFAERS: 48SIDER
US FAERS
32BronchospasmFAERS: 46SIDER
US FAERS
33MalaiseFAERS: 46SIDER
US FAERS
34Respiratory distressFAERS: 44SIDER
US FAERS
35Blood pressure immeasurableFAERS: 43US FAERS
36SyncopeFAERS: 43SIDER
US FAERS
37AngioedemaFAERS: 42OFFSIDES
SIDER
US FAERS
38BradycardiaFAERS: 40SIDER
US FAERS
39PalpitationsFAERS: 40SIDER
US FAERS
40SwellingFAERS: 40
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41AstheniaFAERS: 38SIDER
US FAERS
42Product quality issueFAERS: 36US FAERS
43AnxietyFAERS: 33SIDER
US FAERS
44Myocardial InfarctionFAERS: 32SIDER
US FAERS
45Procedural complicationFAERS: 32US FAERS
46Unevaluable eventFAERS: 31OFFSIDES
US FAERS
47Burning sensationFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Contrast media allergyFAERS: 28US FAERS
49Oral pruritusFAERS: 28US FAERS
50Rash erythematousFAERS: 28US FAERS
51AgitationFAERS: 25SIDER
US FAERS
52Back PainFAERS: 25SIDER
US FAERS
53Respiratory FailureFAERS: 24SIDER
US FAERS
54Oropharyngeal discomfortFAERS: 22OFFSIDES
SIDER
US FAERS
55AsphyxiaFAERS: 21US FAERS
56Anaphylactoid ReactionFAERS: 20SIDER
US FAERS
57FatigueFAERS: 19US FAERS
58Feeling abnormalFAERS: 19SIDER
US FAERS
59Post procedural complicationFAERS: 19US FAERS
60nervous system disorderFAERS: 19SIDER
US FAERS
61Abdominal PainFAERS: 18SIDER
US FAERS
62Choking sensationFAERS: 18OFFSIDES
US FAERS
63DiscomfortFAERS: 18SIDER
US FAERS
64DisorientationFAERS: 18US FAERS
65Injection site extravasationFAERS: 18US FAERS
66Unresponsive to stimuliFAERS: 18US FAERS
67Ventricular FibrillationFAERS: 181997305
10823730
CTD
SIDER
US FAERS
68Feeling ColdFAERS: 17US FAERS
69SomnolenceFAERS: 17SIDER
US FAERS
70Angina PectorisFAERS: 16SIDER
US FAERS
71AphasiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
72Foaming at mouthFAERS: 16US FAERS
73Injection Site ReactionFAERS: 16SIDER
US FAERS
74PresyncopeFAERS: 16US FAERS
75Contrast encephalopathyFAERS: 15US FAERS
76Hypoaesthesia facialFAERS: 15OFFSIDES
US FAERS
77RestlessnessFAERS: 15US FAERS
78Oropharyngeal swellingFAERS: 14OFFSIDES
US FAERS
79PainFAERS: 14
Canada Vigilance: 1
9211770CTD
SIDER
Canada Vigilance
US FAERS
80RetchingFAERS: 14US FAERS
81Skin reactionFAERS: 14
Canada Vigilance: 6
Canada Vigilance
US FAERS
82Abdominal discomfortFAERS: 13SIDER
US FAERS
83Altered state of consciousnessFAERS: 13US FAERS
84AphoniaFAERS: 13OFFSIDES
US FAERS
85LaryngospasmFAERS: 13SIDER
US FAERS
86Acute myocardial infarctionFAERS: 12US FAERS
87Cerebrovascular accidentFAERS: 12SIDER
US FAERS
88Cold sweatFAERS: 12US FAERS
89Infusion Site ExtravasationFAERS: 12US FAERS
90StridorFAERS: 12OFFSIDES
US FAERS
91VertigoFAERS: 12SIDER
US FAERS
92BlindnessFAERS: 11US FAERS
93EpilepsyFAERS: 11US FAERS
94Lip pruritusFAERS: 11US FAERS
95MydriasisFAERS: 11SIDER
US FAERS
96Nasal discomfortFAERS: 11OFFSIDES
US FAERS
97DysarthriaFAERS: 10US FAERS
98Eye irritationFAERS: 10US FAERS
99General physical health deteriorationFAERS: 10US FAERS
100Muscle tightnessFAERS: 10US FAERS
101Acute kidney injuryFAERS: 915986266
17001234
17715118
CTD
US FAERS
102Atrial FibrillationFAERS: 9SIDER
US FAERS
103Blood creatinine increasedFAERS: 9US FAERS
104Drug administration errorFAERS: 9US FAERS
105Musculoskeletal stiffnessFAERS: 9US FAERS
106Oropharyngeal painFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
107PapuleFAERS: 9US FAERS
108Pharyngolaryngeal discomfortFAERS: 9OFFSIDES
US FAERS
109Tongue pruritusFAERS: 9US FAERS
110TrismusFAERS: 9US FAERS
111Visual ImpairmentFAERS: 9SIDER
US FAERS
112ArthralgiaFAERS: 8SIDER
US FAERS
113ChokingFAERS: 8US FAERS
114DiplopiaFAERS: 8OFFSIDES
US FAERS
115EnuresisFAERS: 8OFFSIDES
US FAERS
116HemiparesisFAERS: 8US FAERS
117HypoxiaFAERS: 812631011CTD
US FAERS
118Productive CoughFAERS: 8US FAERS
119AnuriaFAERS: 7US FAERS
120AsthmaFAERS: 7SIDER
US FAERS
121Drug toxicityFAERS: 7US FAERS
122Joint swellingFAERS: 7SIDER
US FAERS
123MonoparesisFAERS: 7US FAERS
124Musculoskeletal discomfortFAERS: 7OFFSIDES
SIDER
US FAERS
125Peripheral swellingFAERS: 7US FAERS
126Sinus TachycardiaFAERS: 7US FAERS
127Urticaria localisedFAERS: 7OFFSIDES
US FAERS
128Brain DeathFAERS: 6US FAERS
129Cardiovascular insufficiencyFAERS: 6US FAERS
130CheilitisFAERS: 6US FAERS
131Disseminated Intravascular CoagulationFAERS: 6US FAERS
132DysgeusiaFAERS: 6SIDER
US FAERS
133IncontinenceFAERS: 6OFFSIDES
US FAERS
134InflammationFAERS: 6SIDER
US FAERS
135Pulmonary EmbolismFAERS: 6US FAERS
136Upper airway obstructionFAERS: 6OFFSIDES
US FAERS
137Blood creatine phosphokinase increasedFAERS: 5US FAERS
138Blood urea increasedFAERS: 5SIDER
US FAERS
139Cardiac procedure complicationFAERS: 5US FAERS
140Cerebral artery occlusionFAERS: 5US FAERS
141Coronary Artery DiseaseFAERS: 5US FAERS
142CryingFAERS: 5OFFSIDES
US FAERS
143Ear discomfortFAERS: 5US FAERS
144Electrocardiogram abnormalFAERS: 5US FAERS
145Electrocardiogram changeFAERS: 5OFFSIDES
US FAERS
146FormicationFAERS: 5US FAERS
147HyperpyrexiaFAERS: 5US FAERS
148Incorrect drug administration rateFAERS: 5OFFSIDES
US FAERS
149Intubation complicationFAERS: 5US FAERS
150Laryngeal discomfortFAERS: 5OFFSIDES
US FAERS
151LethargyFAERS: 5US FAERS
152Medication ErrorFAERS: 5US FAERS
153Mental status changesFAERS: 5US FAERS
154Respiratory DepressionFAERS: 5US FAERS
155Upper respiratory tract congestionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
156Acute respiratory failureFAERS: 4US FAERS
157ArthropathyFAERS: 4SIDER
US FAERS
158BradyphreniaFAERS: 4US FAERS
159Cerebral InfarctionFAERS: 4SIDER
US FAERS
160DeliriumFAERS: 4US FAERS
161DystoniaFAERS: 4US FAERS
162Hypertensive crisisFAERS: 4US FAERS
163Injection site erythemaFAERS: 4US FAERS
164Limb discomfortFAERS: 4US FAERS
165Medical device complicationFAERS: 4US FAERS
166MyoclonusFAERS: 4US FAERS
167NervousnessFAERS: 4US FAERS
168Nonspecific reactionFAERS: 4US FAERS
169ParaplegiaFAERS: 4US FAERS
170PhotophobiaFAERS: 4SIDER
US FAERS
171Respiratory tract congestionFAERS: 4OFFSIDES
US FAERS
172RhinitisFAERS: 4SIDER
US FAERS
173Sense of oppressionFAERS: 4US FAERS
174Skin discomfortFAERS: 4US FAERS
175Skin tightnessFAERS: 4US FAERS
176Sudden deathFAERS: 4US FAERS
177Supraventricular tachycardiaFAERS: 4US FAERS
178VIIth nerve paralysisFAERS: 4US FAERS
179Visual disturbanceFAERS: 4US FAERS
180AbasiaFAERS: 3US FAERS
181AbscessFAERS: 3US FAERS
182AcneFAERS: 3US FAERS
183Alanine Aminotransferase IncreasedFAERS: 3US FAERS
184AmnesiaFAERS: 3SIDER
US FAERS
185Anal sphincter atonyFAERS: 3US FAERS
186Anoxic EncephalopathyFAERS: 3OFFSIDES
US FAERS
187Apallic syndromeFAERS: 3US FAERS
188Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
189AtaxiaFAERS: 3US FAERS
190Blood creatine increasedFAERS: 3US FAERS
191Blood glucose decreasedFAERS: 3US FAERS
192CholangitisFAERS: 3US FAERS
193DermatitisFAERS: 3SIDER
US FAERS
194Documented hypersensitivity to administered productFAERS: 3US FAERS
195Emotional distressFAERS: 3US FAERS
196EpistaxisFAERS: 3SIDER
US FAERS
197ExophthalmosFAERS: 3US FAERS
198Eyelid Function DisorderFAERS: 3OFFSIDES
US FAERS
199HyperventilationFAERS: 3OFFSIDES
US FAERS
200HypothyroidismFAERS: 3SIDER
US FAERS
201HypoventilationFAERS: 3US FAERS
202Injection site urticariaFAERS: 3US FAERS
203Larynx irritationFAERS: 3US FAERS
204LeukocytosisFAERS: 3US FAERS
205LymphadenopathyFAERS: 3US FAERS
206Memory impairmentFAERS: 3US FAERS
207Mental impairmentFAERS: 3US FAERS
208Mouth swellingFAERS: 3US FAERS
209Muscle RigidityFAERS: 3US FAERS
210Nasal pruritusFAERS: 3US FAERS
211Neck PainFAERS: 3SIDER
US FAERS
212Neurological decompensationFAERS: 3US FAERS
213No reaction on previous exposure to drugFAERS: 3US FAERS
214ObstructionFAERS: 3US FAERS
215OpisthotonusFAERS: 3US FAERS
216PneumoniaFAERS: 3US FAERS
217Product use issueFAERS: 3US FAERS
218QuadriplegiaFAERS: 3US FAERS
219SepsisFAERS: 3SIDER
US FAERS
220Septic ShockFAERS: 3US FAERS
221Sinus headacheFAERS: 3OFFSIDES
US FAERS
222Skin lesionFAERS: 3US FAERS
223Skin necrosisFAERS: 3US FAERS
224Status EpilepticusFAERS: 3OFFSIDES
US FAERS
225StrabismusFAERS: 3US FAERS
226Therapy non-responderFAERS: 3US FAERS
227ThrombosisFAERS: 3SIDER
US FAERS
228TinnitusFAERS: 3SIDER
US FAERS
229Accidental exposureFAERS: 2US FAERS
230Acute Coronary SyndromeFAERS: 2SIDER
US FAERS
231Administration site extravasationFAERS: 2US FAERS
232AmimiaFAERS: 2US FAERS
233AneurysmFAERS: 2US FAERS
234ApathyFAERS: 2US FAERS
235ArthritisFAERS: 2US FAERS
236AscitesFAERS: 2US FAERS
237AtelectasisFAERS: 2US FAERS
238Auricular swellingFAERS: 2OFFSIDES
US FAERS
239Blood chloride increasedFAERS: 2US FAERS
240Blood glucose increasedFAERS: 2US FAERS
241Blood mercury abnormalFAERS: 2US FAERS
242Blood potassium decreasedFAERS: 2US FAERS
243Blood pressure fluctuationFAERS: 2US FAERS
244Blood sodium increasedFAERS: 2US FAERS
245Brain HypoxiaFAERS: 2US FAERS
246Cardiac enzymes normalFAERS: 2US FAERS
247CellulitisFAERS: 2US FAERS
248Chemical burn of skinFAERS: 2US FAERS
249Concomitant disease progressionFAERS: 2US FAERS
250ConjunctivitisFAERS: 2SIDER
US FAERS
251Consciousness fluctuatingFAERS: 2US FAERS
252Conversion disorderFAERS: 2US FAERS
253Coronary artery insufficiencyFAERS: 2US FAERS
254DeafnessFAERS: 2US FAERS
255DehydrationFAERS: 2US FAERS
256Drug clearance increasedFAERS: 2US FAERS
257Drug ineffectiveFAERS: 2US FAERS
258DysgraphiaFAERS: 2OFFSIDES
US FAERS
259EmbolismFAERS: 2US FAERS
260Eye painFAERS: 2US FAERS
261Facial PainFAERS: 2US FAERS
262Febrile infectionFAERS: 2OFFSIDES
US FAERS
263Food AllergyFAERS: 2OFFSIDES
US FAERS
264Head discomfortFAERS: 2US FAERS
265Hepatitis CFAERS: 2US FAERS
266HepatitisFAERS: 2US FAERS
267HepatotoxicityFAERS: 2US FAERS
268HydrothoraxFAERS: 2US FAERS
269Incorrect route of drug administrationFAERS: 2US FAERS
270Increased upper airway secretionFAERS: 2US FAERS
271InfectionFAERS: 2US FAERS
272Injection site painFAERS: 2SIDER
US FAERS
273Iodine allergyFAERS: 2US FAERS
274Joint stiffnessFAERS: 2US FAERS
275Kounis SyndromeFAERS: 2US FAERS
276Labile blood pressureFAERS: 2US FAERS
277MacroglossiaFAERS: 2US FAERS
278Maternal exposure during pregnancyFAERS: 2US FAERS
279Mechanical ventilationFAERS: 2US FAERS
280MesenteritisFAERS: 2US FAERS
281MetamorphopsiaFAERS: 2US FAERS
282MonoplegiaFAERS: 2US FAERS
283No adverse eventFAERS: 2US FAERS
284Non-cardiac chest painFAERS: 2US FAERS
285Noninfective sialoadenitisFAERS: 2US FAERS
286NystagmusFAERS: 2US FAERS
287OphthalmoplegiaFAERS: 2US FAERS
288Palmar erythemaFAERS: 2US FAERS
289PetechiaeFAERS: 2US FAERS
290Pharyngolaryngeal PainFAERS: 2US FAERS
291PiloerectionFAERS: 2OFFSIDES
US FAERS
292Poor peripheral circulationFAERS: 2US FAERS
293Poor quality drug administeredFAERS: 2US FAERS
294PosturingFAERS: 2OFFSIDES
US FAERS
295Procedural hypotensionFAERS: 2OFFSIDES
US FAERS
296Product contaminationFAERS: 2US FAERS
297PurpuraFAERS: 2US FAERS
298RalesFAERS: 2US FAERS
299Renal painFAERS: 2SIDER
US FAERS
300Renal tubular necrosisFAERS: 2US FAERS
301Ruptured cerebral aneurysmFAERS: 2US FAERS
302Seizure like phenomenaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Sinus bradycardiaFAERS: 2US FAERS
304Skin irritationFAERS: 2US FAERS
305StomatitisFAERS: 2US FAERS
306Subcutaneous EmphysemaFAERS: 2US FAERS
307Suspected product quality issueFAERS: 2US FAERS
308TachyarrhythmiaFAERS: 2US FAERS
309TracheobronchitisFAERS: 2OFFSIDES
US FAERS
310Transient psychosisFAERS: 2OFFSIDES
US FAERS
311Vascular insufficiencyFAERS: 2US FAERS
312Ventricular hypertrophyFAERS: 2US FAERS
313Accidental exposure to productFAERS: 1US FAERS
314Accidental overdoseFAERS: 1US FAERS
315Acquired diaphragmatic eventrationFAERS: 1US FAERS
316Acute Lung InjuryFAERS: 1US FAERS
317Acute tonsillitisFAERS: 1US FAERS
318AgeusiaFAERS: 1US FAERS
319Air EmbolismFAERS: 1US FAERS
320Allergy to chemicalsFAERS: 1US FAERS
321AmaurosisFAERS: 1US FAERS
322Anorectal discomfortFAERS: 1OFFSIDES
SIDER
US FAERS
323Aortic AneurysmFAERS: 1US FAERS
324Apparent deathFAERS: 1US FAERS
325Application site extravasationFAERS: 1US FAERS
326Atrioventricular BlockFAERS: 1SIDER
US FAERS
327Autoimmune thyroiditisFAERS: 1US FAERS
328Autonomic nervous system imbalanceFAERS: 1SIDER
US FAERS
329Bacterial sepsisFAERS: 1US FAERS
330Band sensationFAERS: 1US FAERS
331Bladder sphincter atonyFAERS: 1US FAERS
332Blood alkaline phosphatase increasedFAERS: 1US FAERS
333Blood parathyroid hormone decreasedFAERS: 1US FAERS
334Blood thyroid stimulating hormone increasedFAERS: 1OFFSIDES
US FAERS
335Brain scan abnormalFAERS: 1US FAERS
336Brain stem syndromeFAERS: 1US FAERS
337Breath HoldingFAERS: 1US FAERS
338Bronchial ObstructionFAERS: 1US FAERS
339BronchiolitisFAERS: 1US FAERS
340BronchitisFAERS: 1US FAERS
341Cardiac stress test abnormalFAERS: 1OFFSIDES
US FAERS
342Cardio-respiratory distressFAERS: 1US FAERS
343CardiomegalyFAERS: 1US FAERS
344Carotid pulse abnormalFAERS: 1US FAERS
345Central Nervous System InfectionFAERS: 1US FAERS
346Central nervous system lesionFAERS: 1US FAERS
347Cerebral dysgenesisFAERS: 1US FAERS
348Cerebrovascular InsufficiencyFAERS: 1US FAERS
349CholelithiasisFAERS: 1US FAERS
350CholestasisFAERS: 1US FAERS
351ClonusFAERS: 1US FAERS
352Coma scale abnormalFAERS: 1US FAERS
353Conjunctival irritationFAERS: 1US FAERS
354Deep Vein ThrombosisFAERS: 1US FAERS
355Device malfunctionFAERS: 1US FAERS
356Device related infectionFAERS: 1US FAERS
357Diabetes MellitusFAERS: 1US FAERS
358Diffuse alveolar damageFAERS: 1OFFSIDES
US FAERS
359Disease ProgressionFAERS: 1US FAERS
360Distributive shockFAERS: 1US FAERS
361Diverticular perforationFAERS: 1OFFSIDES
US FAERS
362Drug exposure during pregnancyFAERS: 1US FAERS
363Dry skinFAERS: 1US FAERS
364DyslexiaFAERS: 1US FAERS
365EczemaFAERS: 1US FAERS
366Electromechanical dissociationFAERS: 1US FAERS
367Emotional disorderFAERS: 1US FAERS
368Enlarged uvulaFAERS: 1US FAERS
369EpidermolysisFAERS: 1US FAERS
370Epigastric discomfortFAERS: 1US FAERS
371Erythema NodosumFAERS: 1US FAERS
372Exposure during breast feedingFAERS: 1US FAERS
373Eye RednessFAERS: 1US FAERS
374Eyelids pruritusFAERS: 1OFFSIDES
US FAERS
375Facial ParesisFAERS: 1US FAERS
376Feeling jitteryFAERS: 1US FAERS
377Feeling of body temperature changeFAERS: 1US FAERS
378FractureFAERS: 1US FAERS
379Gastrointestinal PainFAERS: 1SIDER
US FAERS
380Gastrointestinal erosionFAERS: 1US FAERS
381Gaze palsyFAERS: 1US FAERS
382General physical condition abnormalFAERS: 1US FAERS
383GlossitisFAERS: 1US FAERS
384HemiplegiaFAERS: 1US FAERS
385Hospice CareFAERS: 1US FAERS
386HydrocephalusFAERS: 1US FAERS
387HyperthyroidismFAERS: 1SIDER
US FAERS
388IncoherentFAERS: 1US FAERS
389Incorrect route of product administrationFAERS: 1US FAERS
390Increased bronchial secretionFAERS: 1US FAERS
391IndurationFAERS: 1US FAERS
392InfluenzaFAERS: 1US FAERS
393Infusion site mobility decreasedFAERS: 1US FAERS
394Infusion site painFAERS: 1US FAERS
395Injection site bruisingFAERS: 1US FAERS
396Injection site massFAERS: 1US FAERS
397Injection site vesiclesFAERS: 1US FAERS
398Intestinal angioedemaFAERS: 1US FAERS
399Irritable Bowel SyndromeFAERS: 1US FAERS
400Joint Range of Motion DecreasedFAERS: 1US FAERS
401KetoacidosisFAERS: 1US FAERS
402Large intestine erosionFAERS: 1US FAERS
403Lateral Medullary SyndromeFAERS: 1US FAERS
404Leukocytoclastic vasculitisFAERS: 1US FAERS
405LeukopeniaFAERS: 1US FAERS
406Lichen PlanusFAERS: 1US FAERS
407Livedo ReticularisFAERS: 1US FAERS
408Lymphocyte percentage decreasedFAERS: 1US FAERS
409MalnutritionFAERS: 1US FAERS
410Mechanical urticariaFAERS: 1US FAERS
411Metabolic acidosisFAERS: 1US FAERS
412Muscle FatigueFAERS: 1US FAERS
413Muscle SpasticityFAERS: 1US FAERS
414Musculoskeletal PainFAERS: 1SIDER
US FAERS
415MyalgiaFAERS: 1US FAERS
416Neonatal disorderFAERS: 1US FAERS
417Nephrogenic Systemic FibrosisFAERS: 1US FAERS
418Nephrotic SyndromeFAERS: 1US FAERS
419Nerve injuryFAERS: 1US FAERS
420NeuropathyFAERS: 1SIDER
US FAERS
421Neutrophil percentage increasedFAERS: 1US FAERS
422Night sweatsFAERS: 1US FAERS
423Oculomucocutaneous syndromeFAERS: 1US FAERS
424OliguriaFAERS: 1US FAERS
425Oral mucosal erythemaFAERS: 1US FAERS
426Orthostatic intoleranceFAERS: 1US FAERS
427Oxygen saturation abnormalFAERS: 1US FAERS
428PancreatitisFAERS: 1SIDER
US FAERS
429PancytopeniaFAERS: 1US FAERS
430Paravenous drug administrationFAERS: 1US FAERS
431Pathogen resistanceFAERS: 1US FAERS
432PeritonitisFAERS: 1US FAERS
433Pharmaceutical product complaintFAERS: 1US FAERS
434Pharyngeal swellingFAERS: 1US FAERS
435Pharyngolaryngeal abscessFAERS: 1OFFSIDES
US FAERS
436PneumothoraxFAERS: 1US FAERS
437Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
438Postresuscitation encephalopathyFAERS: 1US FAERS
439Procedural nauseaFAERS: 1US FAERS
440Procedural vomitingFAERS: 1US FAERS
441Product depositFAERS: 1US FAERS
442PrurigoFAERS: 1US FAERS
443PseudoanginaFAERS: 1US FAERS
444Pulmonary FibrosisFAERS: 1US FAERS
445Pulmonary congestionFAERS: 1US FAERS
446Reaction to excipientFAERS: 1US FAERS
447Red man syndromeFAERS: 1OFFSIDES
US FAERS
448Respiratory tract inflammationFAERS: 1US FAERS
449RhinalgiaFAERS: 1US FAERS
450Saliva alteredFAERS: 1US FAERS
451SinusitisFAERS: 1US FAERS
452Skin IndurationFAERS: 1US FAERS
453Somatoform DisorderFAERS: 1US FAERS
454Status AsthmaticusFAERS: 1SIDER
US FAERS
455Stevens-Johnson SyndromeFAERS: 125811541CTD
SIDER
US FAERS
456Stress ulcerFAERS: 1US FAERS
457StressFAERS: 1US FAERS
458Submandibular massFAERS: 1OFFSIDES
US FAERS
459Suspected counterfeit productFAERS: 1US FAERS
460Swelling of eyelidFAERS: 1US FAERS
461Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
462Temperature intoleranceFAERS: 1US FAERS
463Tension HeadacheFAERS: 1US FAERS
464Therapeutic product effect incompleteFAERS: 1US FAERS
465Thermal burnFAERS: 1US FAERS
466ThirstFAERS: 1SIDER
US FAERS
467ThrombocytopeniaFAERS: 17671781CTD
US FAERS
468Tongue discomfortFAERS: 1US FAERS
469Tonic clonic movementsFAERS: 1OFFSIDES
US FAERS
470Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
471Tracheal StenosisFAERS: 1US FAERS
472Transaminases increasedFAERS: 1US FAERS
473Traumatic fractureFAERS: 1US FAERS
474Troponin increasedFAERS: 1US FAERS
475Tryptase decreasedFAERS: 1US FAERS
476Tryptase increasedFAERS: 1US FAERS
477UlcerFAERS: 1US FAERS
478Unresponsive to verbal stimuliFAERS: 1US FAERS
479Urinary RetentionFAERS: 1SIDER
US FAERS
480Urinary tract infectionFAERS: 1US FAERS
481Urine output increasedFAERS: 1US FAERS
482Vanillyl mandelic acid urine increasedFAERS: 1US FAERS
483Vascular ruptureFAERS: 1US FAERS
484Vascular stent occlusionFAERS: 1US FAERS
485VasculitisFAERS: 1SIDER
US FAERS
486Vasoplegia syndromeFAERS: 1US FAERS
487Vein collapseFAERS: 1US FAERS
488Venous thrombosis limbFAERS: 1US FAERS
489Ventricular arrhythmiaFAERS: 1US FAERS
490VerbigerationFAERS: 1US FAERS
491Vertebral artery occlusionFAERS: 1US FAERS
492Vessel puncture site painFAERS: 1OFFSIDES
US FAERS
493Vessel puncture site pruritusFAERS: 1US FAERS
494Vital functions abnormalFAERS: 1US FAERS
495White blood cell count decreasedFAERS: 1US FAERS
496Wound InfectionFAERS: 1US FAERS
497Wrong drug administeredFAERS: 1US FAERS
498intensive careFAERS: 1US FAERS
499jaundiceFAERS: 1US FAERS
500Abdominal Compartment SyndromeOFFSIDES
501Abnormal visionSIDER
502Amnestic DisorderOFFSIDES
503Anticholinergic SyndromeOFFSIDES
504Antidepressant drug clearance increasedOFFSIDES
505AtherosclerosisOFFSIDES
506Blindness, Cortical10974726CTD
507Blood glucose abnormalOFFSIDES
508Blood immunoglobulin A decreasedOFFSIDES
509Blood immunoglobulin M decreasedOFFSIDES
510Blood lactate dehydrogenase increasedSIDER
511Body temperature fluctuationSIDER
512Bone painOFFSIDES
513Brain Ischemia16628721CTD
514BruxismOFFSIDES
515Bullous conditionsSIDER
516Catheter related complicationOFFSIDES
517Congenital tricuspid valve incompetenceOFFSIDES
518Conjunctival depositOFFSIDES
519ConstipationSIDER
520Coronary angioplastyOFFSIDES
521Diabetes InsipidusSIDER
522Diabetes mellitus inadequate controlOFFSIDES
523DysmorphismOFFSIDES
524DyspepsiaSIDER
525Dyspnea8761866CTD
526DysuriaSIDER
527Ear and labyrinth disordersSIDER
528Ear congestionOFFSIDES
529Electrocardiogram ST-T segment depressionOFFSIDES
530Erythema MultiformeSIDER
531Femoral pulse decreasedOFFSIDES
532Glasgow coma scaleOFFSIDES
533Heart Diseases19021282CTD
534HoarsenessSIDER
535InfarctionSIDER
536Intestinal infarctionOFFSIDES
537Intracranial injuryOFFSIDES
538IntubationOFFSIDES
539Iodine uptake increasedOFFSIDES
540Kidney Diseases

View details

CTD
541Lacrimal structural disorderSIDER
542LacrimationSIDER
543LividityOFFSIDES
544MeningismSIDER
545Mental disorder due to a general medical conditionOFFSIDES
546Mood swingsSIDER
547Muscle relaxant therapySIDER
548Myoglobin blood increasedOFFSIDES
549NecrosisSIDER
550NumbnessSIDER
551ParesisSIDER
552Pedal pulse decreasedOFFSIDES
553PharyngitisSIDER
554PingueculaOFFSIDES
555PolyneuropathyOFFSIDES
556Pulmonary HypertensionSIDER
557Rectal tenesmusSIDER
558Respiratory InsufficiencySIDER
559Risus sardonicusOFFSIDES
560ScotomaSIDER
561Seizures8761866CTD
562Sensation of warmthSIDER
563SepticemiaSIDER
564ShiveringSIDER
565Shoulder PainSIDER
566SoporOFFSIDES
567Subglottic edemaSIDER
568Superior Vena Cava SyndromeOFFSIDES
569SweatingSIDER
570TensionSIDER
571ThrombophlebitisSIDER
572Upset stomachSIDER
573Vascular anomalySIDER
574Vasodilation procedureSIDER
575VasodilationSIDER
576VasospasmSIDER
577Vegetative dystoniaSIDER
578Venous ThrombosisSIDER
579effusionSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.